Classification strategy
We analyze intended use, technology, risk, manufacturer, and available evidence to define the compliance path before preparing the dossier.
We support manufacturers, importers, and holders with strategy, dossier preparation, product registration, changes, and lifecycle monitoring for medical devices with INVIMA.
Management is not limited to obtaining an authorization. The value is sustaining portfolio continuity with technical judgment and permanent monitoring.
We analyze intended use, technology, risk, manufacturer, and available evidence to define the compliance path before preparing the dossier.
We coordinate information in Spanish or English with manufacturers and internal teams to structure consistent files for INVIMA.
We support holder models for foreign companies or local portfolios that require stable regulatory administration in Colombia.
We prepare technical defense, clarifications, and support when INVIMA requests additional information during review.
We monitor validity periods, legal and technical changes, renewals, and events that may affect product continuity in the market.
We integrate auditing, regulatory diagnosis, and supplier review when the case requires strengthening the quality system behind the registration.
Each device requires its own reading. Our process organizes the case before moving forward with INVIMA.
We review intended use, technology, accessories, manufacturer, evidence, certificates, and market status.
We establish classification, requirements, documentation gaps, quality dependencies, and submission strategy.
We structure the technical-regulatory file, coordinate support, and respond to INVIMA requests.
We manage changes, renewals, updates, and alerts to prevent market interruptions.
We work with portfolios that combine consumables, equipment, implants, accessories, and technologies with demanding documentation needs.
Let's schedule an initial assessment. We identify risk class, documentation gaps, and the best route for your medical device portfolio.